期刊文献+

睡眠呼吸障碍与心力衰竭并发心房颤动的相关性研究现状 被引量:6

Research Status of Association Between Sleep-disordered Breathing and Atrial Fibrillation in Patients with Heart Failure
下载PDF
导出
摘要 睡眠呼吸障碍与心律失常是心力衰竭常见的合并症,两者相互影响,相互作用,共同促进心力衰竭患者生活质量恶化,住院率和死亡率增加。研究已证实睡眠呼吸障碍与多种心血管疾病的发生及发展具有相关性,但睡眠呼吸障碍与心力衰竭患者心律失常的因果关系仍未明确。现阐述睡眠呼吸障碍与心力衰竭患者发生心房颤动的相关性研究的现状及持续正压通气治疗在这部分人群中的治疗价值。 Sleep-disordered breathing and arrhythmia are common complications of heart failure.They interact with each other and promote the deterioration of quality of life,the increase of hospitalization rate and mortality in patients with heart failure.Studies have confirmed that sleep-disordered breathing is related to the occurrence and development of various cardiovascular diseases,but the causal relationship between sleep-disordered breathing and arrhythmia in patients with heart failure is still unclear.The purpose of this article is to elaborate the research status of the correlation between sleep-disordered breathing and atrial fibrillation in patients with heart failure and the therapeutic value of continuous positive pressure ventilation in this part of the population.
作者 鲁星琴 莫乔莹 陈凤梅 姚亚丽 LU Xingqin;MO Qiaoying;CHENG Fengmei;YAO Yali(The First School of Clinical Medicine of Lanzhou University,Lanzhou 730000,Gansu,China;Heart Center of The First Hospital of Lanzhou University,Lanzhou 730000,Gansu,China)
出处 《心血管病学进展》 CAS 2020年第2期182-185,共4页 Advances in Cardiovascular Diseases
关键词 睡眠呼吸障碍 心力衰竭 心房颤动 心脏性猝死 持续正压通气治疗 Sleep-disordered breathing Heart failure Atrial fibrillation Sudden cardiac death Continuous positive pressure ventilation therapy
  • 相关文献

参考文献4

二级参考文献29

  • 1Muhammad Asrar ul Haq,Chiew Wong,Vivek Mutha,Nagesh Anavekar,Kwang Lim,Peter Barlis,David L Hare.Therapeutic interventions for heart failure with preserved ejection fraction:A summary of current evidence[J].World Journal of Cardiology,2014,6(2):67-76. 被引量:7
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3ACTIVE Writing Group of the ACTIVE investigators,Connolly S,Pogue J,et al. Clopidogrel plus aspirin versus oral antieoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular E- vents ( ACTIVE W ) : a randomized controlled trial [ J ]. Lancet,2006,367 : 1903 - 1912.
  • 4Wasmer K, Eckardt L. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines [ J ]. Eu- ropace, 2011,13 (10) : 1368-1374.
  • 5Ostermayer S, Reschke M, Bininger K, et al. Percutaneous closure of the left atri- al appendage[J]. J Interv Cardiol,2003,16(6) :553-556.
  • 6Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atria/fibrillation[ J]. N Engl J Med,2009,361:1139-1151.
  • 7ACTIVE Investigators, Connolly SJ, Pogue J, et al. Effect of elopidogrel added to aspirin in patients with atrial fibrillation[J]. N Engl J Med, 2009,360(20) : 2066-2078.
  • 8Meyer D. Antiplatelets and stroke outcomes: state of the science[ J]. Crit Care Nuts Clin Noah Am, 2009, 21 (4) :517-528.
  • 9Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrilIation : re- port from the Stockholm Cohort of Atrial Fibrillation [ J ]. Thromb Haemost, 2009,101:367-372.
  • 10Blech S, Ebner T, Ludwig-Schwellinger E, et al. The metabolism and disposi- tion of the oral direct thrombin inhibitor,dabigatran,in humans[J]. Drug Metab Dispos, 2008,36: 386-399.

共引文献90

同被引文献64

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部